Complementary and alternative medicine. Use and challenges among gynaecological cancer patients in Nigeria: experiences in a tertiary health institution - preliminary results
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
Background: Cancer patients have keyed into increasing global interest in the use of Complementary and Alternative Medicine (CAM). There are few studies on CAM use among gynaecological cancer patients in our environment. Objective: To determine the prevalence, pattern and challenges of use of CAM among gynaecological cancer patients in UNTH Enugu, Nigeria. Materials and Methods: This is a descriptive cross sectional study of gynaecological cancer patients seen in a referral tertiary centre in Nigeria. Data was extracted using semi-structured questionnaires and analysed with software for SPSS version 17 using descriptive and inferential statistic. A p value ≤ 0.05 was deemed statistically significant. Result: The mean age of 95 patients studied was 50.9 ± 11 years with CAM use prevalence of 64.3%. The majority (73.8%) used herbal medicine and in 60.7% recommendation was by friends and relatives. Cancer of the cervix was commonest (44.2%) followed by ovarian (32.6%). Most (75%) CAM users reported delayed presentation to hospitals. Longer duration of illness and monthly income less than expenditure were significant factors among CAM users (p = 0.00002 and p = 0.02 respectively). Those that had recommendation of CAM by friends and relatives significantly experienced delayed presentation (p = 0.0017). Conclusion: CAM use was common among gynaecological cancer patients with herbs bring predominantly used in this environment. Respondents whose monthly income was less than their expenses and those whose duration of illness were longer at the point of diagnosis were significantly common users of CAM. CAM use was likely to be abused, hence physicians should inquire into CAM use and offer insights, potential benefits, and adversities of CAM to their patients.
Authors and Affiliations
T. O. Nwankwo, L. Ajah, I. V. Ezeome, U. A. Umeh, U. U. Aniebue
Keywords
Related Articles
- EP ID EP663044
- DOI 10.12892/ejgo4429.2019
- Views 52
- Downloads 0
Immunohistochemical analysis of IQGAP2 in ovarian cancer
IQ motif-containing GTPase-activating protein 2 (IQGAP2) was regarded as a tumor suppressor in some cancers, but its expression pattern in various histological subtypes of ovarian cancer has not been investigated. Immuno...
Role of transvaginal ultrasound in finding endometrial cancer in postmenopausal women with or without bleeding
Purpose of Investigation: To determine the endometrial thickness (ET) threshold to predict high risk of endometrial cancer (EC) in symptomatic and asymptomatic postmenopausal patients. It is also assessed whether additio...
Concurrent chemoradiotherapy combined with immunotherapy is superior to traditional concurrent chemoradiotherapy in the treatment of advanced cervical cancer
Purpose of investigation: In advanced cervical cancer, traditional therapy included concurrent chemoradiotherapy (CCRT), pelvic radiotherapy, and brachytherapy. In the last few years, the development of using of immunoth...
Clinical features and prognostic factors associated with malignant transformation of ovarian mature cystic teratoma
Purpose: To explore the clinical characteristics and identify potential prognostic factors associated with malignant transformation (MT) of ovarian mature cystic teratoma (MCT). Materials and Methods: This study analyzed...
The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro
Purpose of investigation: The pleiotropic factor Y-box binding protein-1 (YB-1) is clinically correlated with breast cancer patients’ poor outcome. Due to the intereference of YB-1 with the estrogen receptor, the authors...